factual
Nine-Month FDA Delay for Manufacturing
Spark delayed its FDA approval request by nine months to finish its manufacturing process, drawing criticism, but the result was the first approved facility of any type making a viral-vector-based drug, located at 38th and Market Street in Philadelphia.
factualpending
Speaker
JeffEvidence Quote
“in addition to getting the first approved, we ultimately got the first approved facility of any type that was making a viral vector-based drug.”
Created: 11/11/2026, 6:53:25 PM
Your notes
Loading notes...